![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 11, 7161-7171, March 17, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Laboratory for Molecular Endocrinology, Western Australian Institute for Medical Research, The Queen Elizabeth II Medical Centre, the Centre for Medical Research, The University of Western Australia, and the Department of Endocrinology & Diabetes, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, Western Australia 6009, Australia
The C-terminal domain of Hsp90 displays independent chaperone activity, mediates dimerization, and contains the MEEVD motif essential for interaction with tetratricopeptide repeat-containing immunophilin cochaperones assembled in mature steroid receptor complexes. An
-helical region, upstream of the MEEVD peptide, helps form the dimerization interface and includes a hydrophobic microdomain that contributes to the Hsp90 interaction with the immunophilin cochaperones and corresponds to the binding site for novobiocin, a coumarin-related Hsp90 inhibitor. Mutation of selected residues within the hydrophobic microdomain significantly impacted the chaperone function of a recombinant C-terminal Hsp90 fragment and novobiocin inhibited wild-type chaperone activity. Prior incubation of the Hsp90 fragment with novobiocin led to a direct blockade of immunophilin cochaperone binding. However, the drug had little influence on the pre-formed Hsp90-immunophilin complex, suggesting that bound cochaperones mask the novobiocin-binding site. We observed a differential effect of the drug on Hsp90-immunophilin interaction, suggesting that the immunophilins make distinct contacts within the C-terminal domain to specifically modulate Hsp90 function. Novobiocin also precluded the interaction of full-length Hsp90 with the p50cdc37 cochaperone, which targets the N-terminal nucleotide-binding domain, and is prevalent in Hsp90 complexes with protein kinase substrates. Novobiocin therefore acts locally and allosterically to induce conformational changes within multiple regions of the Hsp90 protein. We provide evidence that coumermycin A1, a coumarin structurally related to novobiocin, interferes with dimerization of the Hsp90 C-terminal domain. Coumarin-based inhibitors then may antagonize Hsp90 function by inducing a conformation favoring separation of the C-terminal domains and release of substrate.
Received for publication, November 18, 2005 , and in revised form, December 23, 2005.
* This work was supported by grants from the National Health and Medical ResearchCouncil of Australia, the National Breast Cancer Foundation, the Cancer Council of Western Australia and the Sir Charles Gairdner Hospital Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Both authors contributed equally to this work.
2 To whom correspondence should be addressed. Tel.: 61-8-9346-2596; Fax: 61-8-9346-3221; E-mail: tomr{at}cyllene.uwa.edu.au.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Zhang, Z.-H. Li, M. Q. Zhang, M. S. Katz, and B.-X. Zhang Heat Shock Protein 90{beta}1 Is Essential for Polyunsaturated Fatty Acid-induced Mitochondrial Ca2+ Efflux J. Biol. Chem., March 21, 2008; 283(12): 7580 - 7589. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Y. Fan, M. K. Bhangoo, and J. C. Young Hsp90 Functions in the Targeting and Outer Membrane Translocation Steps of Tom70-mediated Mitochondrial Import J. Biol. Chem., November 3, 2006; 281(44): 33313 - 33324. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |